Expressing recombinant proteins is one of the most challenging, but at the same time most important tasks in the life sciences. Irrespective of the specific protein and the downstream applications, ...

At the 17th PEGS Europe Protein & Antibody Engineering Summit, Creative Biolabs didn't just bring a "booth"—it brought a ...

As Companies Diversify Portfolios, Production Processes Need to Be Retooled There has been a maturation of the bioprocessing industry as companies have moved away from a focus on anticancer biologics ...

Protein yield and ease of purification are two important criteria in choosing a system for the expression/ purification of recombinant proteins. The IMPACT (Intein Mediated Purification with an ...

Pichia pastoris is emerging as a versatile, efficient alternative for protein production, bridging microbial and mammalian expression systems.

Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its ...

Abselion, a pioneering life sciences technology company focused on simplifying biomolecule quantification, has expanded its ...

A revolution has occurred in the field of pharmaceutical development due to the development of drugs that target membrane proteins. It is estimated that one-third of currently available drugs target G ...

Antibodies are the number one immune cells that fight against infection and diseases. However, beyond their natural usage, biochemistry has devised several ways in which these antibodies can be ...